Scentech Medical is an Israeli company specializing in the development of advanced medical diagnostic systems that can detect a broad range of diseases through the analysis of volatile organic compounds (VOCs) in exhaled breath. Their core technology involves mapping and commercializing VOC-based biomarkers, which serve as a 'chemical fingerprint' to identify various pathogens, including Covid-19 and its mutations, as well as certain types of cancer.
The company has developed a breathalyzer-like device that can accurately screen for Covid-19 with a reported sensitivity and specificity of 98% during preliminary testing in January 2021. This non-invasive test analyzes thousands of gas compounds in a person's breath sample within minutes, distinguishing the unique VOC patterns associated with the presence of the virus. Scentech Medical's innovative approach extends beyond typical clinical applications, aiming to provide rapid, on-site detection of pathogens in crowded areas such as airports, stadiums, and shopping centers as an additional layer of 'Biological Security.'
In April 2020, Scentech Medical received approval for experimentation of their Covid-19 testing protocol, and the technology was undergoing trials at the Shamir Medical Center as of January 2021, with expected completion by the end of March that year.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.